We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cyberknife Precision Radiation Delivery System for Tumors of the Spine

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00185666
First Posted: September 16, 2005
Last Update Posted: July 14, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Stanford University
  Purpose
The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.

Condition Intervention Phase
Spinal Cord Cancer Brain (Nervous System) Cancers Procedure: Stereotactic radiosurgery Phase 1 Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Cyberknife Precision Radiation Delivery System for Tumors of the Spine

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions [ Time Frame: completed ]

Enrollment: 200
Study Start Date: May 2002
Study Completion Date: May 2006
Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   5 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:- Intra-axial, extra-axial, or vertebral spinal lesion

  • Age > 5
  • Histologic confirmation of malignant primary lesion or radiographic diagnosis of benign or vascular spinal lesion
  • No rapidly deteriorating symptoms of spinal cord compression
  • No instability of the spine
  • Life expectancy > 6 months

Exclusion Criteria:- Patients without tumors of the spine

- Patients younger than 5 years old

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00185666


Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Iris Catrice Gibbs Stanford University